Cargando…

Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy

Diabetic retinopathy (DR) is a major complication of diabetes and a leading cause of blindness worldwide. DR was recently defined as a neurovascular disease associated with tissue-specific neurovascular impairment of the retina in patients with diabetes. Neurovascular cell death is the main cause of...

Descripción completa

Detalles Bibliográficos
Autor principal: Oshitari, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454228/
https://www.ncbi.nlm.nih.gov/pubmed/37629100
http://dx.doi.org/10.3390/ijms241612919
_version_ 1785096139013357568
author Oshitari, Toshiyuki
author_facet Oshitari, Toshiyuki
author_sort Oshitari, Toshiyuki
collection PubMed
description Diabetic retinopathy (DR) is a major complication of diabetes and a leading cause of blindness worldwide. DR was recently defined as a neurovascular disease associated with tissue-specific neurovascular impairment of the retina in patients with diabetes. Neurovascular cell death is the main cause of neurovascular impairment in DR. Thus, neurovascular cell protection is a potential therapy for preventing the progression of DR. Growing evidence indicates that a variety of cell death pathways, such as apoptosis, necroptosis, ferroptosis, and pyroptosis, are associated with neurovascular cell death in DR. These forms of regulated cell death may serve as therapeutic targets for ameliorating the pathogenesis of DR. This review focuses on these cell death mechanisms and describes potential therapies for the treatment of DR that protect against neurovascular cell death.
format Online
Article
Text
id pubmed-10454228
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104542282023-08-26 Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy Oshitari, Toshiyuki Int J Mol Sci Review Diabetic retinopathy (DR) is a major complication of diabetes and a leading cause of blindness worldwide. DR was recently defined as a neurovascular disease associated with tissue-specific neurovascular impairment of the retina in patients with diabetes. Neurovascular cell death is the main cause of neurovascular impairment in DR. Thus, neurovascular cell protection is a potential therapy for preventing the progression of DR. Growing evidence indicates that a variety of cell death pathways, such as apoptosis, necroptosis, ferroptosis, and pyroptosis, are associated with neurovascular cell death in DR. These forms of regulated cell death may serve as therapeutic targets for ameliorating the pathogenesis of DR. This review focuses on these cell death mechanisms and describes potential therapies for the treatment of DR that protect against neurovascular cell death. MDPI 2023-08-18 /pmc/articles/PMC10454228/ /pubmed/37629100 http://dx.doi.org/10.3390/ijms241612919 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Oshitari, Toshiyuki
Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy
title Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy
title_full Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy
title_fullStr Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy
title_full_unstemmed Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy
title_short Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy
title_sort neurovascular cell death and therapeutic strategies for diabetic retinopathy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454228/
https://www.ncbi.nlm.nih.gov/pubmed/37629100
http://dx.doi.org/10.3390/ijms241612919
work_keys_str_mv AT oshitaritoshiyuki neurovascularcelldeathandtherapeuticstrategiesfordiabeticretinopathy